Prediction of Ischemic Stroke Functional Outcomes from Acute-Phase Noncontrast CT and Clinical Information.
Yongkai Liu, Yannan Yu, Jiahong Ouyang, Bin Jiang, Sophie Ostmeier, Jia Wang, Sarah Lu-Liang, Yirong Yang, Guang Yang, Patrik Michel, David S Liebeskind, Maarten Lansberg, Michael E Moseley, Jeremy J Heit, Max Wintermark, Gregory Albers, Greg Zaharchuk
下载PDF
{"title":"Prediction of Ischemic Stroke Functional Outcomes from Acute-Phase Noncontrast CT and Clinical Information.","authors":"Yongkai Liu, Yannan Yu, Jiahong Ouyang, Bin Jiang, Sophie Ostmeier, Jia Wang, Sarah Lu-Liang, Yirong Yang, Guang Yang, Patrik Michel, David S Liebeskind, Maarten Lansberg, Michael E Moseley, Jeremy J Heit, Max Wintermark, Gregory Albers, Greg Zaharchuk","doi":"10.1148/radiol.240137","DOIUrl":null,"url":null,"abstract":"<p><p>Background Clinical outcome prediction based on acute-phase ischemic stroke data is valuable for planning health care resources, designing clinical trials, and setting patient expectations. Existing methods require individualized features and often involve manually engineered, time-consuming postprocessing activities. Purpose To predict the 90-day modified Rankin Scale (mRS) score with a deep learning (DL) model fusing noncontrast-enhanced CT (NCCT) and clinical information from the acute phase of stroke. Materials and Methods This retrospective study included data from six patient datasets from four multicenter trials and two registries. The DL-based imaging and clinical model was trained by using NCCT data obtained 1-7 days after baseline imaging and clinical data (age; sex; baseline and 24-hour National Institutes of Health Stroke Scale scores; and history of hypertension, diabetes, and atrial fibrillation). This model was compared with models based on either NCCT or clinical information alone. Model-specific mRS score prediction accuracy, mRS score accuracy within 1 point of the actual mRS score, mean absolute error (MAE), and performance in identifying unfavorable outcomes (mRS score, >2) were evaluated. Results A total of 1335 patients (median age, 71 years; IQR, 60-80 years; 674 female patients) were included for model development and testing through sixfold cross validation, with distributions of 979, 133, and 223 patients across training, validation, and test sets in each of the six cross-validation folds, respectively. The fused model achieved an MAE of 0.94 (95% CI: 0.89, 0.98) for predicting the specific mRS score, outperforming the imaging-only (MAE, 1.10; 95% CI: 1.05, 1.16; <i>P</i> < .001) and the clinical information-only (MAE, 1.00; 95% CI: 0.94, 1.05; <i>P</i> = .04) models. The fused model achieved an area under the receiver operating characteristic curve (AUC) of 0.91 (95% CI: 0.89, 0.92) for predicting unfavorable outcomes, outperforming the clinical information-only model (AUC, 0.88; 95% CI: 0.87, 0.90; <i>P</i> < .001) and the imaging-only model (AUC, 0.85; 95% CI: 0.84, 0.87; <i>P</i> < .001). Conclusion A fused DL-based NCCT and clinical model outperformed an imaging-only model and a clinical-information-only model in predicting 90-day mRS scores. © RSNA, 2024 <i>Supplemental material is available for this article.</i> See also the editorial by Lee in this issue.</p>","PeriodicalId":20896,"journal":{"name":"Radiology","volume":"313 1","pages":"e240137"},"PeriodicalIF":12.1000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11535867/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Radiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1148/radiol.240137","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
引用
批量引用
Abstract
Background Clinical outcome prediction based on acute-phase ischemic stroke data is valuable for planning health care resources, designing clinical trials, and setting patient expectations. Existing methods require individualized features and often involve manually engineered, time-consuming postprocessing activities. Purpose To predict the 90-day modified Rankin Scale (mRS) score with a deep learning (DL) model fusing noncontrast-enhanced CT (NCCT) and clinical information from the acute phase of stroke. Materials and Methods This retrospective study included data from six patient datasets from four multicenter trials and two registries. The DL-based imaging and clinical model was trained by using NCCT data obtained 1-7 days after baseline imaging and clinical data (age; sex; baseline and 24-hour National Institutes of Health Stroke Scale scores; and history of hypertension, diabetes, and atrial fibrillation). This model was compared with models based on either NCCT or clinical information alone. Model-specific mRS score prediction accuracy, mRS score accuracy within 1 point of the actual mRS score, mean absolute error (MAE), and performance in identifying unfavorable outcomes (mRS score, >2) were evaluated. Results A total of 1335 patients (median age, 71 years; IQR, 60-80 years; 674 female patients) were included for model development and testing through sixfold cross validation, with distributions of 979, 133, and 223 patients across training, validation, and test sets in each of the six cross-validation folds, respectively. The fused model achieved an MAE of 0.94 (95% CI: 0.89, 0.98) for predicting the specific mRS score, outperforming the imaging-only (MAE, 1.10; 95% CI: 1.05, 1.16; P < .001) and the clinical information-only (MAE, 1.00; 95% CI: 0.94, 1.05; P = .04) models. The fused model achieved an area under the receiver operating characteristic curve (AUC) of 0.91 (95% CI: 0.89, 0.92) for predicting unfavorable outcomes, outperforming the clinical information-only model (AUC, 0.88; 95% CI: 0.87, 0.90; P < .001) and the imaging-only model (AUC, 0.85; 95% CI: 0.84, 0.87; P < .001). Conclusion A fused DL-based NCCT and clinical model outperformed an imaging-only model and a clinical-information-only model in predicting 90-day mRS scores. © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Lee in this issue.
从急性期非对比 CT 和临床信息预测缺血性脑卒中的功能预后
背景 基于急性期缺血性脑卒中数据的临床预后预测对于规划医疗资源、设计临床试验和设定患者期望值非常有价值。现有的方法需要个性化的特征,而且往往涉及人工设计、耗时的后处理活动。目的 通过深度学习(DL)模型融合非对比度增强 CT(NCCT)和卒中急性期的临床信息,预测 90 天的改良 Rankin 量表(mRS)评分。材料与方法 这项回顾性研究包括来自四个多中心试验和两个登记处的六个患者数据集的数据。使用基线成像和临床数据(年龄;性别;基线和 24 小时美国国立卫生研究院卒中量表评分;高血压、糖尿病和心房颤动病史)后 1-7 天获得的 NCCT 数据训练了基于 DL 的成像和临床模型。该模型与仅基于 NCCT 或临床信息的模型进行了比较。对模型特异性 mRS 评分预测准确度、实际 mRS 评分 1 分以内的 mRS 评分准确度、平均绝对误差 (MAE) 以及识别不利结果(mRS 评分大于 2 分)的性能进行了评估。结果 共有 1335 名患者(中位年龄 71 岁;IQR 60-80 岁;674 名女性患者)通过六倍交叉验证进行了模型开发和测试,在六个交叉验证褶皱中,每个褶皱的训练集、验证集和测试集中分别有 979、133 和 223 名患者。融合模型预测特定 mRS 评分的 MAE 为 0.94 (95% CI: 0.89, 0.98),优于纯成像模型(MAE, 1.10; 95% CI: 1.05, 1.16; P < .001)和纯临床信息模型(MAE, 1.00; 95% CI: 0.94, 1.05; P = .04)。融合模型预测不利结果的接收者操作特征曲线下面积(AUC)为 0.91 (95% CI: 0.89, 0.92),优于纯临床信息模型(AUC, 0.88; 95% CI: 0.87, 0.90; P < .001)和纯成像模型(AUC, 0.85; 95% CI: 0.84, 0.87; P < .001)。结论 基于 DL 的融合 NCCT 和临床模型在预测 90 天 mRS 评分方面优于仅成像模型和仅临床信息模型。© RSNA, 2024 本文有补充材料。另请参阅本期 Lee 的社论。
本文章由计算机程序翻译,如有差异,请以英文原文为准。